REQUEST A DEMO
Total
USD $0.00
Search more companies

Sengenics Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sengenics Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Engaging in the business of commercialization of cytogenetic and molecular diagnostic product and services and to undertake its related research and development activities.

Headquarters
Mezzanine Floor, Block A, Plaza Zurich, No.12, Jalan Gelanggang, Bukit Damansara
Kuala Lumpur; Federal Territories; Postal Code: 50490

Contact Details: Purchase the Sengenics Sdn. Bhd. report to view the information.

Website: http://www.sengenics.com

Basic Information
Registered Capital:
Purchase the Sengenics Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Sengenics Sdn. Bhd. report to view the information.
Incorporation Date:
July 03, 2008
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sengenics Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
18.71%
Total operating revenue
18.71%
Operating Profit/Loss (EBIT)
21.6%
EBITDA
23.49%
Net Profit/Loss for the Period
21.56%
Total Assets
-13.62%
Total Equity
-37.6%
Operating Profit Margin (ROS)
43.69%
Net Profit Margin
43.64%
Return on Equity (ROE)
-20.62%
Debt/Equity
0.24%
Quick Ratio
-0.09%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?